Subscribe Now
  • Home
  • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Fortune 500
    • Fortune 500 U.S.
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
  • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  • Home
  • Latest
    • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Fortune 500
    • Fortune 500
    • Fortune 500 U.S.
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
  • Finance
    • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  1. home
  1. home
  2. Daraprim

Daraprim

Former KaloBios Pharmaceuticals Chief Executive Officer Martin Shkreli Court Appearance
Health

Martin Shkreli Seriously Didn’t Care About Jacking Up Drug Prices

By Laura Lorenzetti
February 3, 2016
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
Leadership

Martin Shkreli Asks Court to Consider Blocking Subpoena

By Reuters
January 23, 2016
Turing Pharmaceutical CEO Martin Shkreli Arrested For Securities Fraud
Finance

Here’s How Much Martin Shkreli Is Actually Worth

By Jen Wieczner
January 8, 2016
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
Health

Martin Shkreli’s Twitter Account Hacked

By Reuters and Aaron Task
December 21, 2015
US-CRIME-JUSTICE-SHKRELI
Health

Turing Replaces Martin Shkreli with Interim CEO

By Laura Lorenzetti
December 18, 2015
US-CRIME-JUSTICE-SHKRELI
Health

Martin Shkreli Is Reportedly Stepping Down as Turing CEO

By Benjamin Snyder
December 18, 2015
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
Leadership

Martin Shkreli’s 15 Minutes Are Up

By Geoff Colvin
December 18, 2015
Turing Pharmaceutical CEO Martin Shkreli Arrested For Securities Fraud
Health

How Pharmacies Are Dealing with Daraprim After Martin Shkreli’s Arrest

By Reuters
December 18, 2015
Turing Pharmaceutical CEO Martin Shkreli Arrested For Securities Fraud
Finance

Pharma CEO Martin Shkreli Arrested for Securities Fraud

By Geoffrey Smith
December 17, 2015
MSMB Capital Management CIO Martin Shkreli
Health

Express Scripts is Taking on Turing Pharmaceuticals’ 5,000% Price Hike

By Claire Groden
December 1, 2015
MSMB Capital Management CIO Martin Shkreli
Health

Turing Offers Hospitals Discounts on Daraprim Price

By Laura Lorenzetti
November 25, 2015
MSMB Capital Management CIO Martin Shkreli
Health

Turing Says it Will Lower Daraprim Price by the End of the Year

By Laura Lorenzetti
November 4, 2015
Why the drug price scandal won’t be enough to keep down prices
Retail

Why the drug price scandal won’t be enough to keep down prices

By Laura Lorenzetti
October 26, 2015
Imprimis Turing Drug
Health

This company is offering a $1 alternative to Turing’s $750 drug

By Laura Lorenzetti
October 23, 2015
MSMB Capital Management CIO Martin Shkreli
Health

This super-expensive drug is getting a $1 rival

By Benjamin Snyder
October 23, 2015

Most Popular

  • Europe
    Denmark offered to trade Greenland to the U.S. in 1910—and America thought it was crazy
    By Steven Lamy and The Conversation
  • North America
    Gates Foundation plans to give away $9 billion in 2026 to prepare for the 2045 closure while slashing hundreds of jobs
    By Sydney Lake
  • Personal Finance
    Sweden abolished its wealth tax 20 years ago. Then it became a 'paradise for the super-rich'
    By Miranda Sheild Johansson and The Conversation
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Fortune
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.